Testosterone drugs need study on heart risks, FDA panel says
Drugmakers, including Eli Lilly and Co., should conduct new trials to assess the heart risks of testosterone therapies used by millions of men last year, advisers to U.S. regulators said.
Health Care & Life Sciences
Articles
Abortion-related complaints filed against doctors
Attorney General Greg Zoeller's office filed licensing complaints Wednesday against an Illinois doctor facing misdemeanor charges in Indiana and against three physicians who perform abortions in Indianapolis.
Community Health plans $175M expansion of East facilities
Community executives said the investment and projects, which will begin this fall and extend over several years, prove their long-term commitment to the east side of the city.
FDA set to review testosterone-boosting drug usage
Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product.
Lilly to pay AstraZeneca up to $500M in Alzheimer’s push
The two companies will work together to develop AZD3293, which belongs to a novel class of drugs called BACE inhibitors that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Sheriffs: Mentally ill people swamping Indiana jails
County jails have become the "insane asylum" for Indiana as state hospital care for the mentally ill has declined, a sheriff told a legislative committee in Indianapolis on Monday.
Obamacare exchanges boosted coverage, premiums and spending in Indiana
A new study finds that Obamacare boosted enrollment in Indiana’s individual insurance market significantly over what it would have been without the law, but also caused premiums to spike.
Recent wins worth $4B to Lilly market value
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
Lilly cancer drug fares well in late-stage study
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
Lilly receives European marketing OK for new insulin
European regulators have approved a long-lasting insulin from Eli Lilly and Co. and German drugmaker Boehringer Ingelheim that is the subject of patent-infringement litigation with French rival Sanofi.
Feds OKs $1.8 million for health exchange helpers
The U.S. Department of Health and Human Services is sending Indiana money to help the state's health care plan navigators sign up more residents through a federally run exchange.
Conservatives swinging Pence’s way on health reform
Conservatives, after waging war on Obamacare, including its large expansion of Medicaid, are starting to try to propose alternative, conservative ways to achieve its key goals.
Startup Companion Diagnostics trying to work through bankruptcy
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
Obamacare tax rule that split appeals courts gets rehearing
The full U.S. Court of Appeals will rehear a case on Obamacare tax subsidies, granting a government request in a move that may reduce chances of a new Supreme Court showdown over a central part of the law.
Insurer competition stiffens, but tax credits may shrink, on Obamacare exchanges
When Hoosiers start shopping on the Obamacare exchanges again in November, they’ll find new, lower-priced competitors and modest price increases that are much lower than insurers initially proposed. But that doesn’t mean they’ll save money.
While national health care spending growth slowed, Indiana accelerated
Indiana does not appear to be enjoying the rest of the nation’s slowdown in health care spending. Year-to-year growth in Indiana hit 6 percent in 2012 versus 4.5 percent for the nation.
Lilly says new insulin fares better than rival’s in late-stage tests
The Indianapolis-based drugmaker said Thursday that peglispro produced statistically significant lower blood sugar levels in patients when compared to people who took the Sanofi insulin Lantus in two late-stage studies of people with type 1 diabetes.
St. Vincent considers $14M sports performance facility at Marian
Marian University, St. Vincent Health and four amateur sports groups have entered into formal discussions that could result in major developments at the northwest-side campus, the university announced Tuesday.
Feds: AIT’s Evans ‘unjustly enriched’ himself in sale to employees
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
More Indiana options coming on insurance exchange
Officials say Indiana residents will have more than triple the number of health insurance plans to choose from when the federal insurance exchange enrollment period starts in November. A a 5-percent average increase in exchange premiums is expected.